VCM
AGN

Vivaldi Capital Management’s Allergan plc AGN Stock Holding History

Vivaldi Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,648
Closed -$1.71M – 293
2020
Q1 		$1.71M Buy
9,648
+4,171
+76% +$785K 0.39% 54
2019
Q4 		$1.05M Buy
5,477
+2,844
+108% +$513K 0.25% 76
2019
Q3 		$443K Buy
+2,633
New +$429K 0.1% 135

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Vivaldi Capital Management's AGN Position: Q2 2020 in Review

Vivaldi Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,648 shares — an estimated $1.71M sold.

Vivaldi Capital Management first reported a position in AGN in Q3 2019 and held it in 3 quarters. The position peaked at $1.71M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Vivaldi Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Vivaldi Capital Management sold 9,648 Allergan plc shares in Q2 2020, an estimated $1.71M.
  • Vivaldi Capital Management first reported a position in Allergan plc in Q3 2019 and held it in 3 quarters.
  • Vivaldi Capital Management's Allergan plc position peaked at $1.71M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Vivaldi Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.